RegenLab USA, which manufactures devices for the production of regenerative cell therapy, on Monday opened its research and manufacturing lab at Brooklyn Army Terminal, with plans to make it its headquarters for the Americas.
Its location in the Brooklyn Army Terminal is part of BioBAT, an incubator created out of a partnership between SUNY Downstate Health Sciences University and the New York City Economic Development Corporation to renovate the terminal for biotech and life science tenants.
RegenLab USA, which has origins in Switzerland, has secured 15,000 square feet in BioBAT for the initial stage of a $10 million project to establish a new global headquarters, said CEO Antoine
→ Continue reading at Crain's New York Business
